Straits Times Index
3,090.31 +17.32 (+0.56%) Nikkei
33,431.51 -55.38 (-0.17%) Hang Seng
16,830.30 -212.58 (-1.25%) FTSE 100
7,529.35 +75.60 (+1.01%) Bitcoin USD
39,513.27 +748.38 (+1.93%) CMC Crypto 200
802.76 +11.20 (+1.41%)
REGN Jan 2024 650.000 call
| Previous close | 141.20 |
| Open | 141.20 |
| Bid | 174.20 |
| Ask | 184.00 |
| Strike | 650.00 |
| Expiry date | 2024-01-19 |
| Day's range | 141.20 - 141.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 22 |
Insider MonkeyJP Morgan’s Top 15 Stock Picks for 2023 and Now
In this piece, we will take a look at JP Morgan’s top 15 stock picks for 2023 and most recent stock picks. If you want to skip our introduction to the world’s biggest bank in terms of assets, its latest performance, and other details, then check out JP Morgan’s Top 5 Stock Picks for 2023. […]
GlobeNewswireRegeneron to Host Investor Call and Webcast on December 14, 2023 to Provide Updates Across Its Hematology Portfolio
TARRYTOWN, N.Y., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will host a conference call and simultaneous webcast to provide an update on the company's hematology portfolio on Thursday, December 14, 2023 at 8:30 AM ET. This investor call follows Regeneron data updates presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, from December 9-12, 2023. The webcast may be accessed from the "Investors & Media" page of Regeneron's w
ZacksRegeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study
Regeneron (REGN) and partner Sanofi (SNY) post positive data from the second COPD study and plan to submit a sBLA to the FDA by the end of 2023.
